This meeting is scheduled to take place virtually online from November 10 -15. The following is a pre-conference program pertaining to Immunotherapy Resistance and Failure that is on November 9th:
Session I: Defining Immune Checkpoint Inhibitor Resistance
|
| 9:05 a.m. | Definitions of Resistance and Gaps in Current Understanding
Ryan J. Sullivan, MD - Massachusetts General Hospital |
| 9:35 a.m. | Mechanisms of Resistance and Possible New Combinations for Overcoming Them
Paolo A. Ascierto, MD - Istituto Nazionale Tumori IRCCS Fondazione Pascale |
| 9:55 a.m. | Immunotherapy Primary and Acquired Resistance
Antoni Ribas, MD, PhD - University of California Los Angeles |
Dr. Paolo A. Ascierto, MD is the Principal Investigator for Idera's Illuminate - 301 Phase lll trial in Napoli, Italy.
https://www.sitcancer.org/2020/program/pre-conference-programs/immunotherapyresistance
|
